Dr. Joseph Tuscano of the UC Davis Comprehensive Cancer Center is the most active Kyprolis KOL in California

September 3, 2020

By: Stephen

Today, SpeakerBook will take a deep dive into the RX product Kyprolis from Amgen. Kyprolis is a prescription medication used to treat people who have received one to three previous treatments for multiple myeloma.

Now that we have an understanding of what Kyprolis does, let's take a look at Amgen's most recent earnings report.

Yahoo finance announced that Kyprolis recorded sales of $253 million, in the second-quarter 2020 earnings report for Amgen. Kyprolis sales were down 5% year over year, hurt by lower volumes due to reduced multiple myeloma patient visits to doctors.

The financial reports Kyprolis as one of its top RX products with year over year growth for Amgen. Understanding the scale and distribution network of any RX product is a massive undertaking.

Amgen, like all other pharmaceutical companies, employs sales reps and teams of people to interact with hospitals and institutions all over the country. In 2013, the government implemented a mandate called the Sunshine Act that was used to record every interaction between a Pharma manufacturer and the Key Opinion Leader (KOL) they interacted with at any hospital or institution.

This means that all of Amgen's Kyprolis interactions with KOLs are all recorded by law and available for public record. The 2019 Sunshine Act Data is available to the public, but the amount of data recorded is overwhelming and can be extremely hard to navigate. There are tools to search one single KOL’s name, but there is no product that allows you to search a specific RX product category and targeted sales territory to locate additional KOLs.

You can use SpeakerBook to search for new KOLs. In this example, I’m new to Pharma sales and am looking to better understand Kyprolis. The goal is to find new KOLs in California that are related to treatments for multiple myeloma.

Let's use SpeakerBook to search for the product Kyprolis in the state of California.

Top 10 most active Amgen Kyprolis KOLs in California:

Image KOL Speaking Fees
SpeakerBook Dr. Joseph Tuscano Key Opinion Leaders Dr. Joseph Tuscano $44,400
SpeakerBook Dr. James Berenson Key Opinion Leaders Dr. James Berenson $36,600
SpeakerBook Dr. Amitabha Mazumder Opinion Leaders Dr. Amitabha Mazumder $21,600
SpeakerBook Dr. Robert A. Vescio Key Opinion Leaders Dr. Robert A. Vescio $18,600
SpeakerBook Dr. Mohammadbagher Ziari Key Opinion Leaders Dr. Mohammadbagher Ziari $17,500
SpeakerBook Dr. Amrita Krishnan Key Opinion Leaders Dr. Amrita Krishnan $12,650
SpeakerBook Dr. Michaela Liedtke Key Opinion Leaders Dr. Michaela Liedtke $8,236
SpeakerBook Dr. Mohammad H. Fekrazad Key Opinion Leaders Dr. Mohammad H. Fekrazad $8,000
SpeakerBook Dr. Sanjay Sharma Key Opinion Leaders Dr. Sanjay Sharma $7,468
SpeakerBook Dr. Leroy Wayne Keiser Key Opinion Leaders Dr. Leroy Wayne Keiser $5,600

This SpeakerBook RX product search revealed 12 KOLs in the state of California with the 10 most active KOLs listed above. SpeakerBook shows that Dr. Joseph Tuscano of Sacramento, CA has the most active speaker program for the RX product Kyprolis in 2019.

SpeakerBook Dr. Joseph-Tuscano-Kyprolis-KOL
SpeakerBook Dr. Joseph-Tuscano-Kyprolis-KOL

Dr. Tuscano’s speaking fees for Kyprolis totaled $44,400 in speaker fees which made up 24.3% of his total pharmaceutical industry payments of $200,120.

Dr. Tuscano spoke exclusively for 3 RX products Revlimid, Adcetris, and Kyprolis. Kyprolis and Adcetris made up 47.7% of Dr. Tuscano’s total Pharma industry payments with Revlimid taking up 50.5%.

Dr. Joseph Tuscano’s speaker program schedule for 2019:

  • January 3 speaking programs for Kyprolis and Revlimid totaling $10,600 in speaker fees from Amgen and Celgene

  • February 2 speaking programs for Revlimid totaling $7,000 in speaker fees from Celgene

  • March 7 speaking programs for Adcetris and Revlimid totaling $19,805 in speaker fees from Seattle Genetics and Celgene

  • April 5 speaking programs for Kyprolis, Adcetris, and Revlimid totaling $12,400 in speaker fees from Amgen, Seattle Genetics, and Celgene

  • May 7 speaking programs for Kyprolis, Adcetris, and Revlimid totaling $18,900 in speaker fees from Amgen, Seattle Genetics, and Celgene

  • June 4 speaking programs for Kyprolis and Revlimid totaling $10,045 in speaker fees from Amgen and Celgene

  • July 4 speaking programs for Revlimid totaling $20,250 in speaker fees from Celgene

  • August 3 speaking programs for Adcetris and Revlimid totaling $11,850 in speaker fees from Seattle Genetics and Celgene

  • September 3 speaking programs for Kyprolis and Revlimid totaling $12,450 in speaker fees from Amgen and Celgene

  • October 1 speaker programs for Adcetris totaling $3,000 in speaker fees from Seattle Genetics

  • November 8 speaking programs for Adcetris and Kyprolis totaling $22,800 in speaker fees from Seattle Genetics and Amgen

  • December 2 speaking programs for Adcetris and Kyprolis totaling $7,100 in speaker fees from Seattle Genetics and Amgen

SpeakerBook has done a great job at breaking down Dr. Joseph Tuscano’s speaker program schedule for 2019. SpeakerBook has found Dr. Tuscano through a detailed RX product search for the RX product Kyprolis from Amgen. Now that we have located the most active KOLs we can use SpeakerBook as a personal or team Pharma CRM.

You can use the SpeakerBook app to review and locate top KOLs for any RX product and sales territory in the USA. SpeakerBook is available to download for free in the iOS store.

Try SpeakerBook in the iOS app store today